AFZAL U REHMAN

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology JOHNSON CITY, NY NPI 1124070925

General Payments — all program years on this page

$10,135.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 330
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $793.92 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $793.9221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,280.6655
2019 $2,852.5985
2020 $373.2123
2021 $1,469.6038
2022 $1,260.3243
2023 $2,105.5065
2024 $793.9221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077705121 Biosense Webster, Inc. $107.15 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081718588 Lexicon Pharmaceuticals, Inc. $19.48 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081718590 Lexicon Pharmaceuticals, Inc. $21.13 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087269101 Novartis Pharmaceuticals Corporation $13.93 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087269109 Novartis Pharmaceuticals Corporation $13.14 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087269111 Novartis Pharmaceuticals Corporation $16.39 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087269113 Novartis Pharmaceuticals Corporation $17.23 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092299779 Boston Scientific Corporation $18.72 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101247521 E.R. Squibb & Sons, L.L.C. $16.73 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101247527 E.R. Squibb & Sons, L.L.C. $16.56 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104607454 AstraZeneca Pharmaceuticals LP $13.94 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111686233 Amgen Inc. $26.32 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111686235 Amgen Inc. $20.71 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124855201 Abbott Laboratories $20.61 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130903766 PFIZER INC. $18.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131272289 PFIZER INC. $17.95 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138820624 Edwards Lifesciences Corporation $127.48 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140159229 Inari Medical, Inc. $115.86 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145807155 BIOTRONIK INC. $127.47 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892627 Kiniksa Pharmaceuticals International, plc $26.30 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892664 Kiniksa Pharmaceuticals International, plc $18.82 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.